Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
Condition: Anxiety Disorder; Depression; Fatigue; Leydig Cell Tumor; Ovarian Sarcoma; Ovarian Stromal Cancer; Pain; Peritoneal Carcinomatosis; Pseudomyxoma Peritonei; Recurrent Breast Cancer; Recurrent Cervical Cancer; Recurrent Endometrial Carcinoma; Recurrent Fallopian Tube Cancer; Recurrent Gestational Trophoblastic Tumor; Recurrent Ovarian Epithelial Cancer; Recurrent Ovarian Germ Cell Tumor; Recurrent Primary Peritoneal Cavity Cancer; Recurrent Uterine Sarcoma; Recurrent Vaginal Cancer; Recurrent Vulvar Cancer
MeSH terms: Breast Neoplasms; Sarcoma; Fallopian Tube Neoplasms; Carcinoma, Ovarian Epithelial; Endometrial Neoplasms; Carcinoma; Peritoneal Neoplasms; Vulvar Neoplasms; Vaginal Neoplasms; Trophoblastic Neoplasms; Pseudomyxoma Peritonei; Leydig Cell Tumor; Recurrence; Anxiety Disorders
Study type: Interventional

Summary: 
      This pilot clinical trial studies stress reduction in improving quality of life in patients
      with recurrent gynecologic or breast cancer. Participating in a stress reduction program may
      help improve quality of life in patients with gynecologic or breast cancer.
    

Detailed description: 
      PRIMARY OBJECTIVES:

      I. To refine the intervention. II. Test the acceptability, feasibility, and clinical
      appropriateness of the intervention.

      III. To provide a preliminary test of its efficacy.

      OUTLINE:

      Patients participate in a multi-component intervention based on cognitive and behavioral
      principles comprising mindfulness-based stress reduction (MBSR), an intervention to promote
      hopefulness, and a problem solving approach which navigates around obstacles or generates
      alternatives when goals become blocked. Additional topics may be covered as indicated by
      clinical need and patients goals. Biobehavioral components include addressing social and
      disease-specific quality of life, and pain education. Intensive treatment sessions continue
      weekly for 16 weeks followed by 2 biweekly and 2 monthly maintenance sessions.

      After completion of study treatment, patients are followed up at 28 weeks.
    

Intervention name(s): questionnaire administration; quality-of-life assessment; psychosocial assessment and care; behavioral intervention; cognitive intervention; educational intervention
Intervention type(s): Other; Procedure; Procedure; Behavioral; Other; Other
Intervention description(s): Ancillary studies; Patients will participate in a quality life assessment.; Participate in multi-component biobehavioral intervention; Participate in multi-component biobehavioral intervention; A multi-component intervention based on cognitive and behavioral principles will be used. It combines effective intervention strategies selected for their relevance to patients with recurrent cancer.; Participate in multi-component biobehavioral intervention
Other intervention name(s): quality of life assessment; Ancillary studies; psychosocial assessment; psychosocial assessment/care; psychosocial care; psychosocial care/assessment; psychosocial studies; Behavior Conditioning Therapy; Behavior Therapy; Behavioral Modification; Behavioral Therapy; Behavioral Treatment; intervention, educational
Intervention model: Single Group Assignment
Masking: None (Open Label)
Primary purpose: Supportive Care
Keywords: psychological intervention; breast cancer; gynecologic cancer